133 related articles for article (PubMed ID: 24382186)
1. Allergen immunotherapy may exert an extra-anti-allergic activity in children.
Ciprandi G; Incorvaia C; Dell'Albani I; Di Cara G; Barberi S; Puccinelli P; Frati F;
J Biol Regul Homeost Agents; 2013; 27(4):1053-7. PubMed ID: 24382186
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial.
Acquistapace F; Agostinis F; Castella V; Kantar A; Novembre E; Perrone MR; Pietrasanta M; Sambugaro R; Milani M
Pediatr Allergy Immunol; 2009 Nov; 20(7):660-4. PubMed ID: 19320852
[TBL] [Abstract][Full Text] [Related]
3. Allergy immunotherapy: reduced health care costs in adults and children with allergic rhinitis.
Hankin CS; Cox L; Bronstone A; Wang Z
J Allergy Clin Immunol; 2013 Apr; 131(4):1084-91. PubMed ID: 23375206
[TBL] [Abstract][Full Text] [Related]
4. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
5. Is response to allergen immunotherapy a good phenotypic marker for differentiating between allergic rhinitis and mixed rhinitis?
Smith AM; Rezvani M; Bernstein JA
Allergy Asthma Proc; 2011; 32(1):49-54. PubMed ID: 21262098
[TBL] [Abstract][Full Text] [Related]
6. Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study.
Hankin CS; Cox L; Lang D; Bronstone A; Fass P; Leatherman B; Wang Z
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):79-85. PubMed ID: 20143650
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of allergic rhinitis, previously alleviated with allergen immunotherapy, after autologous bone marrow transplant.
Kelso JM
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):316-8. PubMed ID: 12269654
[TBL] [Abstract][Full Text] [Related]
8. [The effects of subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination in management of perennial allergic rhinitis].
Fu Z; Lin X; Cai F; Wang G; Deng H; Li Q; Wang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 26(16):744-6. PubMed ID: 23213755
[TBL] [Abstract][Full Text] [Related]
9. [Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy].
Scheinmann P; Pham Thi N; Karila C; de Blic J
Arch Pediatr; 2012 Mar; 19(3):330-4. PubMed ID: 22306361
[TBL] [Abstract][Full Text] [Related]
10. Does allergen immunotherapy for allergic rhinitis prevent asthma?
Arshad SH
Ann Allergy Asthma Immunol; 2022 Sep; 129(3):286-291. PubMed ID: 35500864
[TBL] [Abstract][Full Text] [Related]
11. The POLISMAIL lesson: sublingual immunotherapy may be prescribed also in polysensitized patients.
Ciprandi G; Incorvaia C; Puccinelli P; Scurati S; Masieri S; Frati F
Int J Immunopathol Pharmacol; 2010; 23(2):637-40. PubMed ID: 20646360
[TBL] [Abstract][Full Text] [Related]
12. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
13. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of candidates for allergen immunotherapy.
Ciprandi G; Incorvaia C; Dell'Albani I; Masieri S; Cavaliere C; Puccinelli P; Frati F;
Allergy Rhinol (Providence); 2013; 4(2):e77-81. PubMed ID: 24124641
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
[TBL] [Abstract][Full Text] [Related]
16. Immediate adverse reactions to immunotherapy.
Can D; Demir E; Tanaç R; Gülen F; Yenigün A
J Investig Allergol Clin Immunol; 2003; 13(3):177-80. PubMed ID: 14635467
[TBL] [Abstract][Full Text] [Related]
17. Sublingual immunotherapy to house dust mite in pediatric patients with allergic rhinitis and asthma: a retrospective analysis of clinical course over a 3-year follow-up period.
Nuhoglu Y; Ozumut SS; Ozdemir C; Ozdemir M; Nuhoglu C; Erguven M
J Investig Allergol Clin Immunol; 2007; 17(6):375-8. PubMed ID: 18088019
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy and safety of sublingual immunotherapy of allergic rhinitis in children between 4 and 5 years age group and 11 and 12 years age group].
Cui L; Wang ZN; Xu ZQ; Xia ZF
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jan; 48(1):17-21. PubMed ID: 23656810
[TBL] [Abstract][Full Text] [Related]
19. The health economics of allergen immunotherapy.
Hankin CS; Cox L; Bronstone A
Immunol Allergy Clin North Am; 2011 May; 31(2):325-41, x. PubMed ID: 21530823
[TBL] [Abstract][Full Text] [Related]
20. Clinical Efficacy of Allergen-Specific Immunotherapy from Patient and Physician Perspectives.
Shin YS; Jung JW; Park JW; Choi JH; Kwon JW; Lee S; Kim JH; Lee SM; Ahn YM; Han MY;
Yonsei Med J; 2019 May; 60(5):446-453. PubMed ID: 31016906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
